Intraoperative Molecular Imaging
LightPath® is an intraoperative imaging device designed for rapidly acquiring molecular images of surgical tissue specimens.
Features & Benefits
- Rapid molecular imaging of surgical tissue specimens in the operating room
- Imaging modalities include Cerenkov Luminescence Imaging and flexible digital autoradiography
- 3-5 minute scan time
- Molecular specificity
- Simple sample preparation
- High spatial resolution
- Compatible with all commercially-available PET imaging agents
Information
Publications
Use of intraoperative 68Gallium-PSMA Cerenkov luminescence imaging for surgical margins in radical prostatectomy – a feasibility study. Eur Assoc Urol, 18(1):e782-e783, 2019.
Intraoperative assessment of tumor resection margins in breast-conserving surgery using 18F-FDG Cerenkov luminescence imaging: a first-in-human feasibility study. J Nucl Med. 2017;58(6):891-898.
Performance evaluation of the LightPath imaging system for intra-operative Cerenkov luminescence imaging. Physica Medica. 2018; 52:22–128.
Cerenkov luminescence imaging for image-guided cancer surgery. Clin Transl Imaging. 2016; 4(5):353-366.
 | The LightPath® Imaging System has a CE Mark and is approved for sale in the European Union. The device has not received marketing authorization from the FDA. |